CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma
Fingerprint
Dive into the research topics of 'CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma'. Together they form a unique fingerprint.